Skip to main content

Clinical Use of Amniotic Fluid in Osteoarthritis: A Source of Cell Therapy

  • Chapter
  • First Online:
Regenerative Medicine Using Pregnancy-Specific Biological Substances

Abstract

Nature is the finest physician: it takes care of everyone because its concerns are universal and genuine; however, it always follows certain guidelines and principles and scientists can learn from these. Giving birth is an act of nature through which the realm of creation is opened to the mother. Nature comes from the Latin word Natus, “to be born.” During birth, if nothing is present, what will prevent infection from affecting the newly born baby? Nature’s concern can be seen when the vagina is washed, prior to birth, by a fine baby-friendly liquid containing cell suspension and antibacterial elements, which gives it a disinfectant property; it also possesses lubricant and cell therapy properties that are crucial for the mother and the child at the critical time of birth. This fluid is known as the amniotic fluid. So far, no one appears to have used this fluid for any therapeutic purpose for more than 70 years in the practice of modern medicine. However, there has been some recent awareness about amniotic fluid as a source of mesenchymal stem cells, which can be converted into any cell type given the niche or the environment for its transdifferentiation property, the implication being that it can help in regeneration in a degenerating system.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Johnson HL. Observation on the prevention of post operative peritonitis and abdominal adhesions. Surg Gynac Obstet. 1927;XLV:612.

    Google Scholar 

  2. Johnson HL. An exposition and the preparation and administration of the amniotic fluid concentrate. N Engl J Med. 1935;CCXII:557.

    Article  Google Scholar 

  3. Jones ES. Joint lubrication. Lancet. 1936;1:1043.

    Article  Google Scholar 

  4. Lacey JT. Amniotic fluid - A clinical study. Ann Surg. 1935;Cl:529.

    Article  Google Scholar 

  5. Collins DH. The pathology of sinovial effusions. J Pathol Bacteriol. 1936;XLII:113.

    Article  Google Scholar 

  6. Mandell S. The use of amniotic fluid concentrate on orthopedic conditions. J Bone Joint Surg Am. 1938;20:167-177.

    Google Scholar 

  7. Leung VY, Chan D, Cheung KM. Regeneration of intervertebral disc by mesenchymal stem cells: potentials, limitations, and future direction. Eur Spine J. 2006;15(suppl 3):S406-413.

    Article  PubMed  Google Scholar 

  8. Sobajima S, Vadala G, Shimer A, Kim JS, Gilbertson LG, Kang JD. Feasibility of a stem cell therapy for intervertebral disc degeneration. Spine J. 2008;8(6):888-896.

    Article  PubMed  Google Scholar 

  9. Kaviani A, Perry TE, Dzakovic A, Jennings RW, Ziegler MM, Fauza DO. The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg. 2001;36(11):1662-1665.

    Article  CAS  PubMed  Google Scholar 

  10. Prusa AR, Hengstschlager M. Amniotic fluid cells and human stem cell research: a new connection. Med Sci Monitor. 2002;8(11):RA253-257.

    Google Scholar 

  11. Medina-Gomez P, del Valle M (1988) Cultivo de celas de liquido amniotico. Analisis de colonias, metafases e indice mitotico, con fin de descartar contaminacion de celulas maternas. Ginecol Obstet Mex. 56122–1

    Google Scholar 

  12. In’t Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood. 2003;102(4):1548-1549.

    Article  Google Scholar 

  13. Prusa AR, Marton E, Rosner M, et al. Neurogenic cells in human amniotic fluid. Am J Obstet Gynecol. 2004;191(1):309-314.

    Article  PubMed  Google Scholar 

  14. Ref: Royal College of General Practitioners. Morbidity Statis­tics from General Practice 1991–92. London, U.K.: HMSO; 1995.

    Google Scholar 

  15. McAlindon TE, Cooper C, Kirwan JR, Dieppe P. Deter­minants of disability in osteoarthritis of the knee. Ann Rheum Dis. 1993;52:258-262.

    Article  CAS  PubMed  Google Scholar 

  16. Sjögren P, Halling A. Quality of reporting randomised clinical trials in dental and medical research. Br Dental J. 2002;192:100-103.

    Article  Google Scholar 

  17. Jadad AR. Randomised Controlled Trials. London, U.K.: BMJ Books; 1998:28-36.

    Google Scholar 

  18. O’Donoghue K, Choolani M, Chan J, et al. Identification of fetal mesenchymal stem cells in maternal blood: implications for non-invasive prenatal diagnosis. Mol Hum Reprod. 2003;9:497-502.

    Article  PubMed  Google Scholar 

  19. O’Donoghue K, Chan J, de La Fuente J, et al. Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet. 2004;364:179-182.

    Article  PubMed  Google Scholar 

  20. Perin L, Giuliani S, Jin D, et al. Renal differentiation of amniotic fluid stem cells. Cell Prolif. 2007;40(6):936-948.

    Article  CAS  PubMed  Google Scholar 

  21. Friedman DM, Moore ME. The efficacy of intraarticular steroids in osteoarthritis: a double-blind study. J Rheumatol. 1980;7:850-856.

    CAS  PubMed  Google Scholar 

  22. Mazieres B, Masquelier AM, Capron MH. A French controlled multicenter study of ntraarticular orgotein versus intraarticular corticosteroids in the treatment of knee osteoarthritis: a one-year follow up. J Rheumatol Suppl. 1991;27:134-137.

    CAS  PubMed  Google Scholar 

  23. Cederlof S, Jonson G. Intraarticular prednisolone injection for osteoarthritis of the knee. A double blind test with placebo. Acta Chir Scand. 1966;132:532-537.

    CAS  PubMed  Google Scholar 

  24. Dieppe PA, Sathapatayavongs B, Jones HE, Bacon PA, Ring EF. Intra-articular steroids in osteoarthritis. Rheumatol Rehabil. 1980;19:212-217.

    Article  CAS  PubMed  Google Scholar 

  25. Raynauld J, Buckland-Wright C, Ward R, et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee. Arth Rheum. 2003;48:370-377.

    Article  CAS  Google Scholar 

  26. American College of Rheumatology subcommittee on osteoarthritis guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee. Arth Rheum. 2000;43:1905-1915.

    Article  Google Scholar 

  27. Ayral X. Injections in the treatment of osteoarthritis. Best Pract Res Clin Rehumatol. 2001;15:609-626.

    Article  CAS  Google Scholar 

  28. Gaffney K, Ledingham J, Perry JD. Intra-articular triamcinolone hexacetonide in kneeosteoarthritis: factors influencing the clinical response. Ann Rheumat Dis. 1995;54:379-381.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

The Department of Science and Technology, Government of West Bengal supported the investigator with a research grant during his tenure at Bijoygarh State Hospital from 1999 to 2006.The work started in Bijoygarh Government Hospital (1999–2006) and was followed up at Vidyasagore Government Hospital subsequently. The author gratefully acknowledges the support of the patients who volunteered for this research work. Guidance of Prof K. L. Mukherjee of Biochemistry and Prof M. K. Chhetri, former Director of Health Services and Prof B. K. Dutta of Orthopaedics are also acknowledged.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer London

About this chapter

Cite this chapter

Bhattacharya, N. (2011). Clinical Use of Amniotic Fluid in Osteoarthritis: A Source of Cell Therapy. In: Bhattacharya, N., Stubblefield, P. (eds) Regenerative Medicine Using Pregnancy-Specific Biological Substances. Springer, London. https://doi.org/10.1007/978-1-84882-718-9_38

Download citation

  • DOI: https://doi.org/10.1007/978-1-84882-718-9_38

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84882-717-2

  • Online ISBN: 978-1-84882-718-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics